NCT00075751View on ClinicalTrials.gov

Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2007

Conditions
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

gemcitabine hydrochloride

Given IV

DRUG

carboplatin

Given IV

DRUG

bortezomib

Given IV

Trial Locations (1)

78245

Southwest Oncology Group, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00075751 - Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter